10 June 2016 SATVI Labs approved by ACTG

10 Jun 2016 - 12:45


On 9 June 2016 the AIDS Clinical Trial Group announced the approval of laboratories of the South African Tuberculosis Vaccine Initiative  to conduct tests in A5343, in support of  Protocol A5343, A Trial of the Safety, Tolerability, and Pharmacokinetics of Bedaquiline and Delamanid.